2 unloved FTSE 100 stocks I’d buy before it’s too late

With the FTSE 100 rising recently, one Fool looks at two companies that have been left behind and why this could represent a good opportunity to buy.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As the UK moves out of lockdown and the economy’s wheels begin to turn a little quicker, the FTSE 100 has gained a boost and has tracked upwards quickly from the start of April. Good news for the broader economy, however, does not always equate to good news for individual companies.

I’ve pulled out two Footsie companies that have had a difficult time of late but, as a result, may represent an opportunity for me to buy. I will personally be following their progress closely to make the most of their lower cost before a potential rise.

AstraZeneca

The chances are that you’ve read quite a bit about AstraZeneca (LSE: AZN) in the news lately. The FTSE 100 company has had a bit of a rollercoaster ride of late, soaring as its Covid-19 vaccine began its rollout across Europe and now hitting a tricky spot as reports over potential blood clot risks of this vaccine arose.

It’s my view that the market has overreacted to the news because the vaccine represents only a relatively small part of its overall business. In fact, the crown jewel for AstraZeneca is its portfolio of oncology treatments that achieved sales of $11.4bn in 2020, with the three major treatments in that portfolio growing sales by over 35% year-on-year.

Currently, the company won’t take any profits from its vaccine until July of this year, after which there are estimates it will bring in $2bn in sales in 2022. Not a small sum but when its top selling oncology product, Tagrisso, is already bringing in $4.3bn and growing, it does put this in perspective.

With the negative PR likely to rumble on, shares in the company could continue their downward trend from highs of last year. This is definitely one I’ll be watching and potentially buying into should they drop even further.

HSBC

Covid-19 has hit many businesses on the FTSE 100 hard, though many are recovering as the UK begins to open up. Some are recovering quicker than others, and one that still has some way to go before getting back to pre-pandemic levels is HSBC (LSE: HSBA). Prior to the pandemic, shares in the company were selling at just under 600p but have now fallen to around the 430p level.

This isn’t unusual in the banking sector, other companies are also fighting their way back to previous levels, but for HSBC the situation is a little different. Not only is it down on early 2020 figures, it’s also been on a decline since reaching highs of almost 800p in 2018.

Like other UK banks, there has been significant amount of restructuring taking place since the financial crisis of 2008, and current CEO, Noel Quinn, has previously announced plans to reduce the cost base of the business to increase earnings, as it deals with the current low interest rate environment.

One factor that could significantly boost earnings is the company’s performance in Asia, particularly China. HSBC has a strong presence in China and signalled back in February that it would pivot its focus towards Asia where it generates 90% of the company’s profit.

With some Asian countries, specifically China, faring much better during the pandemic and likewise seeing a rapid rate of recovery, this could see HSBC’s strategic position there pay off. This is why I’ll keep an eye on the company to see whether it can begin to outperform its FTSE 100 peers in the future, with a view to buying for the long term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ben Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has recommended HSBC Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »